Step-down management of gastroesophageal reflux disease.
about
Overutilization of proton-pump inhibitors: what the clinician needs to knowAcid suppression and the risk of Clostridium difficile infectionStrategies for discontinuation of proton pump inhibitors: a systematic reviewDiagnosis and treatment of gastroesophageal reflux disease.Pulmonary or otolaryngologic extraesophageal manifestations in patients with gastroesophageal reflux diseaseProton pump inhibitors: potential cost reductions by applying prescribing guidelines.Structured management strategy versus usual care for gastroesophageal reflux disease: rationale for pooled analysis of five European cluster-randomized trialsReview article: cost-effectiveness of different GERD management strategies.Treatment of uncomplicated reflux diseaseReview article: alternative approaches to the long-term management of GERD.Use of proton pump inhibitors and risk of osteoporosis-related fractures.Diet and lifestyle modifications in the management of gastroesophageal reflux disease.Step-down approach to behavioural weight loss treatment: a pilot of a randomised clinical trial.Update on health-related quality of life in patients with gastroesophageal reflux disease.The relationship among proton pump inhibitors, bone disease and fracture.Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?Patient barriers to and enablers of deprescribing: a systematic review.A benefit-risk assessment of the use of proton pump inhibitors in the elderly.Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors.Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.Weaning of proton pump inhibitors in patients with suspected laryngopharyngeal reflux disease.Medical Treatment of Gastroesophageal Reflux Disease.The Quality of Care for Gastroesophageal Reflux Disease.Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.Proton pump inhibitor prescribing patterns in the UK: a primary care database study.Outcome after Discontinuation of Proton Pump Inhibitors at a Residential Care Site: Quality Improvement Project.Issues Related to BID Dosing of PPIs.Editorial: just how "difficult" is it to withdraw PPI treatment?When to stop?Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database.A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.Outcomes From a Pharmacist - led Proton Pump Inhibitor Stewardship Program at a Single Institution.Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid.Early referral for esophageal pH monitoring is more cost-effective than prolonged empiric trials of proton-pump inhibitors for suspected gastroesophageal reflux disease.Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.Internists' Perceptions of Proton Pump Inhibitor Adverse Effects and Impact on Prescribing Practices: Results of a Nationwide Survey.Review of Proton Pump Inhibitor Overuse in the US Veteran Population.The Medical Management of Gastro-Oesophageal Reflux Disease.On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis
P2860
Q24634086-EAF703EF-925E-409C-9323-FFD22BE2A980Q26823599-7FBDC548-8264-4BCA-AD5C-DE946AE42376Q27022227-0374C568-DCE7-45A0-9146-E3905EFBF0D5Q34047646-8C759E67-ECF3-4A68-A995-D41DBE047C72Q34390738-340A60C4-653D-4D37-85E4-7EEB0E914541Q34481174-EAADCAE4-0554-4AFA-AE3B-377175917877Q34565708-D0011E3B-94F3-408C-8CCD-157FEAC4F2CFQ34669268-38952FAE-7038-4DF0-B405-A2B2A29A1103Q36204260-A2E9D535-9043-4D99-9D88-455D974E62D3Q36319540-F8A3207F-B6A1-4AD7-9944-99EB71E02ED2Q36803505-CD97E300-1FD6-4C30-A05A-9AFB2A759FD5Q37205411-24BA8EA1-406F-4B11-9364-6EE5F006BBA7Q37398930-3D5B646A-1742-46F6-8117-6032D578CC41Q37609235-D61C6CD7-DFF0-4A27-8C73-1FC30216B0F9Q37877712-01AD7B5B-7A2C-4BDE-9256-F6D77B19172DQ38011261-D964E5A9-75DC-495F-9038-A9D48F366C51Q38126375-78D79818-748D-4672-A983-11B6E9356B20Q38196383-B55F2255-A193-4E80-9A2C-1B262457EE5BQ38266846-A7952AD8-628A-4B8C-A7A2-A4A77E803664Q38646393-C05DB7B4-9916-4D3B-BA44-04EE943D4BBAQ38668590-A360077B-A6AA-43C6-9AAD-2D0AD55B1216Q38892032-6CB927C3-C2F3-4370-9DF7-A20746D48C1FQ39060076-B001C942-BE0A-4EB3-AD3A-BA3B334F6D88Q39276611-76BB9C36-1DF1-478A-B0B3-652B4BD4E0CAQ39714357-A343D43F-8E86-4CE6-BEFB-A54E5B6E7AA8Q40146435-8138420F-C7C4-481D-BF99-6D478C978643Q42035997-28FE5515-3517-469C-B365-04787FD5117EQ42981048-DE3A3357-CF93-438F-BA9F-180ECD288EE6Q42993505-E0D34F97-0BE1-4CAD-84D4-92B7E9C87AD8Q47984107-1B2F779F-06D9-4593-B117-20A442938972Q48124606-0E80496B-0A59-4BCC-BA4B-6C25646934FCQ50046112-C9694A0C-F1BE-4FFA-AC8A-07CC9654744AQ50734992-488C1B22-EAFF-482E-949C-4B993A9224F0Q51142763-0C9738E2-E30F-4BC3-847B-C95B66C3FCE7Q53228159-6F00BC5C-470B-42EB-855B-FBF5C0EAFDDBQ55113683-2B3745FE-A309-4D42-82D2-EC3E196BCD9AQ55230586-13ECA9C8-8087-463A-9170-BBE863443616Q55233746-D8A92B93-0A12-48AB-BEEB-4071824009B6Q58787771-C48F5B03-9E7F-49EB-B28B-7F14FD9EEC99
P2860
Step-down management of gastroesophageal reflux disease.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Step-down management of gastroesophageal reflux disease.
@en
Step-down management of gastroesophageal reflux disease.
@nl
type
label
Step-down management of gastroesophageal reflux disease.
@en
Step-down management of gastroesophageal reflux disease.
@nl
prefLabel
Step-down management of gastroesophageal reflux disease.
@en
Step-down management of gastroesophageal reflux disease.
@nl
P2093
P356
P1433
P1476
Step-down management of gastroesophageal reflux disease.
@en
P2093
Hoffman RM
Sonnenberg A
Swanson KM
P304
P356
10.1053/GAST.2001.28649
P407
P50
P577
2001-11-01T00:00:00Z